Patient readmission and mortality after colorectal surgery for colon cancer: impact of length of stay relative to other clinical factors.

PubWeight™: 2.29‹?› | Rank: Top 2%

🔗 View Article (PMID 22289517)

Published in J Am Coll Surg on January 29, 2012

Authors

Eric B Schneider1, Omar Hyder, Benjamin S Brooke, Jonathan Efron, John L Cameron, Barish H Edil, Richard D Schulick, Michael A Choti, Christopher L Wolfgang, Timothy M Pawlik

Author Affiliations

1: Department of Surgery and Center for Surgical Trials and Outcomes Research, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Articles citing this

Variation in surgical-readmission rates and quality of hospital care. N Engl J Med (2013) 5.27

Exploring the burden of inpatient readmissions after major cancer surgery. J Clin Oncol (2014) 2.84

Risk factors for 30-day hospital readmission among general surgery patients. J Am Coll Surg (2012) 2.15

Influence of patient, physician, and hospital factors on 30-day readmission following pancreatoduodenectomy in the United States. JAMA Surg (2013) 2.03

Is the readmission rate a valid quality indicator? A review of the evidence. PLoS One (2014) 1.56

Patient readmission and mortality after surgery for hepato-pancreato-biliary malignancies. J Am Coll Surg (2012) 1.55

Assessing readmission after general, vascular, and thoracic surgery using ACS-NSQIP. Ann Surg (2013) 1.45

A novel risk scoring system reliably predicts readmission after pancreatectomy. J Am Coll Surg (2015) 1.43

Adjusted Age-Adjusted Charlson Comorbidity Index Score as a Risk Measure of Perioperative Mortality before Cancer Surgery. PLoS One (2016) 1.43

Readmission predicts 90-day mortality after esophagectomy: Analysis of Surveillance, Epidemiology, and End Results Registry linked to Medicare outcomes. J Thorac Cardiovasc Surg (2015) 1.41

Readmission After Resections of the Colon and Rectum: Predictors of a Costly and Common Outcome. Dis Colon Rectum (2015) 1.41

Higher Charlson Comorbidity Index Scores are associated with readmission after orthopaedic surgery. Clin Orthop Relat Res (2013) 1.27

Disparities in surgical 30-day readmission rates for Medicare beneficiaries by race and site of care. Ann Surg (2014) 1.04

Referral patterns and treatment choices for patients with hepatocellular carcinoma: a United States population-based study. J Am Coll Surg (2013) 1.02

The impact of EHR and HIE on reducing avoidable admissions: controlling main differential diagnoses. BMC Med Inform Decis Mak (2013) 0.96

Cost-effectiveness analysis of chromoendoscopy for colorectal cancer surveillance in patients with ulcerative colitis. Gastrointest Endosc (2013) 0.94

The real world effectiveness of hematopoietic transplant among elderly individuals with multiple myeloma. J Natl Cancer Inst (2015) 0.89

Hospital readmission is associated with poor survival after esophagectomy for esophageal cancer. Ann Thorac Surg (2014) 0.88

General and vascular surgery readmissions: a systematic review. J Am Coll Surg (2014) 0.88

Readmission incidence and associated factors after a hepatic resection at a major hepato-pancreatico-biliary academic centre. HPB (Oxford) (2014) 0.87

Assessing short- and long-term outcomes among black vs white Medicare patients undergoing resection of colorectal cancer. Am J Surg (2013) 0.86

A validated, risk assessment tool for predicting readmission after open ventral hernia repair. Hernia (2015) 0.81

Watch and wait approach to rectal cancer: A review. World J Gastrointest Surg (2015) 0.80

Factors associated with 30-day hospital readmission after hysterectomy. Obstet Gynecol (2015) 0.80

Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (GOG 218): an NRG oncology/gynecologic oncology group study (ADS-1236). Gynecol Oncol (2015) 0.80

Evaluation of 30-day hospital readmission after surgery for advanced-stage ovarian cancer in a medicare population. J Clin Oncol (2014) 0.79

Postoperative Functional Recovery After Gastrectomy in Patients Undergoing Enhanced Recovery After Surgery: A Prospective Assessment Using Standard Discharge Criteria. Medicine (Baltimore) (2016) 0.78

Risk of readmission after laparoscopic vs. open colorectal surgery. Int J Colorectal Dis (2015) 0.78

Functional genomic analyses of the gut microbiota for CRC screening. Nat Rev Gastroenterol Hepatol (2013) 0.78

Clinical outcomes of the very elderly undergoing enhanced recovery programmes in elective colorectal surgery. Ann R Coll Surg Engl (2016) 0.77

Socioeconomic Factors Are Associated With Readmission After Lobectomy for Early Stage Lung Cancer. Ann Thorac Surg (2016) 0.77

Preoperative impairment is associated with a higher postdischarge level of care. J Surg Res (2014) 0.77

Predicting Individualized Postoperative Survival for Stage II/III Colon Cancer Using a Mobile Application Derived from the National Cancer Data Base. J Am Coll Surg (2015) 0.75

Readmission After Ileostomy Creation: Retrospective Review of a Common and Significant Event. Ann Surg (2017) 0.75

A retrospective observational study of length of stay in hospital after colorectal cancer surgery in England (1998-2010). Medicine (Baltimore) (2016) 0.75

Readmissions After Colon Cancer Surgery: Does It Matter Where Patients Are Readmitted? J Oncol Pract (2016) 0.75

Postoperative Complications: Looking Forward to a Safer Future. Clin Colon Rectal Surg (2016) 0.75

Hospital Readmission Through the Emergency Department. Trauma Mon (2016) 0.75

Age-adjusted charlson comorbidity index score as predictor of prolonged postoperative ileus in patients with colorectal cancer who underwent surgical resection. Oncotarget (2017) 0.75

Readmission rates due to venous thromboembolism in cancer patients after abdominopelvic surgery, a retrospective chart review. Support Care Cancer (2014) 0.75

Risk Factors for Postoperative Complications Following Diverting Loop Ileostomy Takedown. J Gastrointest Surg (2017) 0.75

Unplanned admission after gastrectomy as a consequence of fast-track surgery: a comparative risk analysis. Gastric Cancer (2015) 0.75

Factors associated with hospital readmission following diverting ileostomy creation. Tech Coloproctol (2017) 0.75

Identifying causes for high readmission rates after stoma reversal. Surg Endosc (2013) 0.75

Articles by these authors

The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg (2009) 16.82

Circulating mutant DNA to assess tumor dynamics. Nat Med (2007) 10.33

DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science (2011) 10.26

Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med (2014) 8.36

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature (2012) 8.31

International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology (2012) 7.22

1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg (2006) 7.18

DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol (2009) 6.43

Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg (2002) 6.24

Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol (2006) 5.78

Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg (2004) 5.12

Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med (2011) 5.03

A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group. Ann Surg (2013) 4.95

Altered telomeres in tumors with ATRX and DAXX mutations. Science (2011) 4.60

NCCN Clinical Practice Guidelines in Oncology: colon cancer. J Natl Compr Canc Netw (2009) 4.41

Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet (2011) 4.38

Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg (2002) 3.82

Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg (2007) 3.73

Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci U S A (2011) 3.51

Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital. J Clin Oncol (2008) 3.51

Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery (2007) 3.42

Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol (2003) 3.40

Gallbladder cancer: the role of laparoscopy and radical resection. Ann Surg (2007) 3.38

NCCN Clinical Practice Guidelines in Oncology: rectal cancer. J Natl Compr Canc Netw (2009) 3.37

Assessment of complications after pancreatic surgery: A novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg (2006) 3.35

Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res (2004) 3.31

Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res (2003) 3.23

Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg (2009) 3.15

Evaluating the impact of a single-day multidisciplinary clinic on the management of pancreatic cancer. Ann Surg Oncol (2008) 3.14

Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am J Surg Pathol (2006) 3.01

Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis. Hepatology (2014) 2.98

New staging system and a registry for perihilar cholangiocarcinoma. Hepatology (2011) 2.89

MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls. Clin Cancer Res (2013) 2.71

Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol (2006) 2.66

Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod Pathol (2003) 2.63

Surgical management of bile duct injuries sustained during laparoscopic cholecystectomy: perioperative results in 200 patients. Ann Surg (2005) 2.58

American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol (2009) 2.52

A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation. Ann Surg (2011) 2.50

Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res (2003) 2.49

Laparoscopic distal pancreatectomy is associated with significantly less overall morbidity compared to the open technique: a systematic review and meta-analysis. Ann Surg (2012) 2.48

A critical role for elastin signaling in vascular morphogenesis and disease. Development (2003) 2.47

SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer. Clin Cancer Res (2009) 2.44

Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. Am J Pathol (2002) 2.44

Is there a difference in survival between right- versus left-sided colon cancers? Ann Surg Oncol (2008) 2.43

Expanding criteria for resectability of colorectal liver metastases. Oncologist (2008) 2.39

Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula. J Gastrointest Surg (2004) 2.35

Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol (2002) 2.35

Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol (2009) 2.35

In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses. J Exp Med (2005) 2.28

Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol (2007) 2.26

Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am J Pathol (2002) 2.22

Intrahepatic cholangiocarcinoma: management options and emerging therapies. J Am Coll Surg (2013) 2.22

Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all 'chronic pancreatitis'? Am J Surg Pathol (2003) 2.20

MUC4 expression increases progressively in pancreatic intraepithelial neoplasia. Am J Clin Pathol (2002) 2.18

Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol (2011) 2.13

Implementation of a surgical comprehensive unit-based safety program to reduce surgical site infections. J Am Coll Surg (2012) 2.11

miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts. Clin Cancer Res (2012) 2.10

Major bile duct injuries associated with laparoscopic cholecystectomy: effect of surgical repair on quality of life. Ann Surg (2002) 2.09

Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. Surgery (2006) 2.07

Thoracic endovascular aneurysm repair, race, and volume in thoracic aneurysm repair. J Vasc Surg (2012) 2.07

Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res (2002) 2.07

Solitary colorectal liver metastasis: resection determines outcome. Arch Surg (2006) 2.06

Limitations of claims and registry data in surgical oncology research. Ann Surg Oncol (2007) 2.06